This seasoned analyst highlights 3 stocks to buy that will bring you success in Q4 2022

A seasoned analyst has presented 3 stocks to buy that will be great choices for the rest of 2022, but easily well beyond that horizon. The selection may surprise you, but these are quality companies where he sees significant discounts and undervaluations of up to 30%, which is already a decent discount and investment opportunity.

Dave Sekera

Who is Dave Sekera? Strategist, investor, former CEO and analyst with over 25 years of experience in the securities markets. I was personally surprised by his top 3 stock picks as they are both high potential and higher risk stocks. Each stock in this selection is significantly undervalued in his opinion and offers decent potential for further upside, of course he also gives reasons that lead him to this belief.

Zimmer Biomet $ZBH

Shares of $ZBH have lost -35.65% since the beginning of the year.

$ZBH is a company in the healthcare sector that has been in business for a really long time, dating back to 1927.

Dave Sekera: We think there are a lot of…